Shivani Singh 1, Alexa A. Pragman 2, and Leopoldo N. Segal 1
doi : 10.1164/rccm.202109-2024ed
Volume 204, Issue 10, PP. 1117–1119
V. Marco Ranieri 1, Tommaso Tonetti 1, and Stefano Nava 2
doi : 10.1164/rccm.202109-2116ed
Volume 204, Issue 10, PP. 1120–1121
Daniel-Costin Marinescu 1,2 and Christopher J. Ryerson 1,2
doi : 10.1164/rccm.202108-1899ed
Volume 204, Issue 10, PP. 1122–1124
Charles A. Powell
doi : 10.1164/rccm.202108-1985ed
Volume 204, Issue 10, PP. 1124–1126
Juliann M. Di Fiore 1,2, Richard J. Martin 1,2, and Thomas M. Raffay 1,2
doi : 10.1164/rccm.202109-2077ed
Volume 204, Issue 10, PP. 1126–1127
Mateus Ramos Amorim 1, Raouf Amin 2,3, and Vsevolod Y. Polotsky 1
doi : 10.1164/rccm.202108-1989ed
Volume 204, Issue 10, PP. 1128–1130
J. Lucian Davis 1,2,3 and William Checkley 4,5
doi : 10.1164/rccm.202107-1795ed
Volume 204, Issue 10, PP. 1130–1131
Sumita B. Khatri , Jonathan M. Iaccarino , Amisha Barochia , Israa Soghier , Praveen Akuthota , Anna Brady , Ronina A. Covar , Jason S. Debley , Zuzana Diamant , Anne M. Fitzpatrick , David A. Kaminsky , Show All...
doi : 10.1164/rccm.202109-2093st
Volume 204, Issue 10, PP. e97–e109
The fractional exhaled nitric oxide (FENO) test is a point-of-care test that is used in the assessment of asthma.
Fernando Sergio Leitao Filho 1,2, Hiroto Takiguchi 1,2,3, Kentaro Akata 1,2,4, Seung Won Ra 1,2,5, Ji-Yong Moon 1,2,6, Hyun Kuk Kim 1,2,7, Yuji Cho 1,2,8, Kei Yamasaki 1,2,9, Stephen Milne 1,2,10, Julia Yang 1,2, Cheng Wei Tony Yang 1,2, Xuan Li 1,2, Corey Nislow 11, Stephan F. van Eeden 1,2, Tawimas Shaipanich 1,2, Stephen Lam 1,2,12, Janice M. Leung 1,2, and Don D. Sin 1,2
doi : 10.1164/rccm.202102-0289oc
Volume 204, Issue 10, PP. 1143–1152
Inhaled corticosteroids (ICS) are commonly prescribed with long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease (COPD). To date, the effects of ICS therapy on the airway microbiome in COPD are unknown.
Todd Sarge 1, Elias Baedorf-Kassis 2, Valerie Banner-Goodspeed 1, Victor Novack 3, Stephen H. Loring 1, Michelle N. Gong 4, Deborah Cook 5, Daniel Talmor 1, and Jeremy R. Beitler 6; for the EPVent-2 Study Group
doi : 10.1164/rccm.202009-3539oc
Volume 204, Issue 10, PP. 1153–1163
In acute respiratory distress syndrome (ARDS), the effect of positive end-expiratory pressure (PEEP) may depend on the extent to which multiorgan dysfunction contributes to risk of death, and the precision with which PEEP is titrated to attenuate atelectrauma without exacerbating overdistension.
Sreyankar Nandy 1,2,3*, Rebecca A. Raphaely 1,3*, Ashok Muniappan 3,4, Angela Shih 3,5, Benjamin W. Roop 1,2, Amita Sharma 3,6, Colleen M. Keyes 1,3, Thomas V. Colby 7, Hugh G. Auchincloss 3,4, Henning A. Gaissert 3,4, Michael Lanuti 3,4, Christopher R. Morse 3,4, Harald C. Ott 3,4, John C. Wain 3,4,8, Cameron D. Wright 3,4, Maria L. Garcia-Moliner 9, Maxwell L. Smith 7, Paul A. VanderLaan 3,10, Sarita R. Berigei 1,2, Mari Mino-Kenudson 3,5, Nora K. Horick 3,11, Lloyd L. Liang 1, Diane L. Davies 4, Margit V. Szabari 1,2,3, Peter Caravan 3,12,13, Benjamin D. Medoff 1,3 Andrew M. Tager 1,3†, Melissa J. Suter 1,2,3, and Lida P. Hariri 1,2,3,5
doi : 10.1164/rccm.202104-0847oc
Volume 204, Issue 10, PP. 1164–1179
Early, accurate diagnosis of interstitial lung disease (ILD) informs prognosis and therapy, especially in idiopathic pulmonary fibrosis (IPF). Current diagnostic methods are imperfect. High-resolution computed tomography has limited resolution, and surgical lung biopsy (SLB) carries risks of morbidity and mortality. Endobronchial optical coherence tomography (EB-OCT) is a low-risk, bronchoscope-compatible modality that images large lung volumes in vivo with microscopic resolution, including subpleural lung, and has the potential to improve the diagnostic accuracy of bronchoscopy for ILD diagnosis.
Kezhong Chen 1*, Jing Bai 2*, Alexandre Reuben 3, Heng Zhao 1, Guannan Kang 1, Chunliu Zhang 2, Qingyi Qi 4, Yaping Xu 2, Shawna Hubert 3,5, Lianpeng Chang 2, Yanfang Guan 2,6, Lin Feng 7, Kai Zhang 8, Kaitai Zhang 7, Xin Yi 2,6, Xuefeng Xia 2, Shujun Cheng 7, Fan Yang 1‡, Jianjun Zhang 3,5‡, and Jun Wang 1‡
doi : 10.1164/rccm.202101-0119oc
Volume 204, Issue 10, PP. 1180–1192
Ground-glass opacity (GGO)-associated lung cancers are common and radiologically distinct clinical entities known to have an indolent clinical course and superior survival, implying a unique underlying biology. However, the molecular and immune characteristics of GGO-associated lung nodules have not been systemically studied.
Erik A. Jensen 1, Robin K. Whyte 2, Barbara Schmidt 1,3, Dirk Bassler 4, Nestor E. Vain 5,6, and Robin S. Roberts 3; for the Canadian Oxygen Trial Investigators
doi : 10.1164/rccm.202105-1150oc
Volume 204, Issue 10, PP. 1192–1199
Bronchopulmonary dysplasia increases the risk of disability in extremely preterm infants. Although the pathophysiology remains uncertain, prior exposure to intermittent hypoxemia may play a role in this relationship.
Amélia Madani 1*, Gabriel Pitollat 2*, Eléonore Sizun 1, Laura Cardoit 2, Maud Ringot 1, Thomas Bourgeois 1, Nelina Ramanantsoa 1, Christophe Delclaux 1,3, Stéphane Dauger 1,4, Marie-Pia d’Ortho 1,5, Muriel Thoby-Brisson 2, Jorge Gallego 1, and Boris Matrot 1
doi : 10.1164/rccm.202104-0887oc
Volume 204, Issue 10, PP. 1200–1210
Congenital central hypoventilation syndrome (CCHS) is characterized by life-threatening sleep hypoventilation and is caused by PHOX2B gene mutations, most frequently the PHOX2B27Ala/+ mutation, with patients requiring lifelong ventilatory support. It is unclear whether obstructive apneas are part of the syndrome.
Robert J. Blount 1, Ha Phan 2,3, Trang Trinh 2,3, Hai Dang 2,3, Cindy Merrifield 2,4,5, Michael Zavala 1, Joseph Zabner 1, Alejandro P. Comellas 1, Emma M. Stapleton 1, Mark R. Segal 6, John Balmes 4,7*, Nguyen Viet Nhung 2,8, and Payam Nahid 2,4,5
doi : 10.1164/rccm.202101-0136oc
Volume 204, Issue 10, PP. 1211–1221
The Southeast Asian tuberculosis burden is high, and it remains unclear if urban indoor air pollution in this setting is exacerbating the epidemic.
Ravi Manglani 1, Nargis Jilani 2, Mohammad Raji 2, and Oleg Epelbaum 1
doi : 10.1164/rccm.202012-4500im
Volume 204, Issue 10, PP. 1222–1223
Shishir Rao 1, Madhav Chopra 2, and Swathy Puthalapattu 2
doi : 10.1164/rccm.202010-3985im
Volume 204, Issue 10, PP. e110–e112
Sivasubramanium V. Bhavani 1*, Yuan Luo 2*, William D. Miller 3, Lazaro N. Sanchez-Pinto 2, Xuan Han 3, Chengsheng Mao 2, Burhaneddin Sand?kç? 4, Monica E. Peek 3, Craig M. Coopersmith 1, Kelly N. Michelson 2, and William F. Parker 3‡
doi : 10.1164/rccm.202106-1453le
Volume 204, Issue 10, PP. 1224–1227
Nhat-Nam Le-Dong 1*, Jean-Benoit Martinot 2,3*‡, Nathalie Coumans 2, Valérie Cuthbert 2, Renaud Tamisier 4,5, Sébastien Bailly 4,5, and Jean-Louis Pépin 4,5
doi : 10.1164/rccm.202103-0680le
Volume 204, Issue 10, PP. 1227–1231
Yunjie Huang 1*, Grace Paul 2*, Jesun Lee 1*, Sunitha Yarlagadda 1, Karen McCoy 2, and Anjaparavanda P. Naren 1‡
doi : 10.1164/rccm.202101-0090le
Volume 204, Issue 10, PP. 1231–1235
Zhenzhen Zheng 1*, Riken Chen 2,3,4,5*, Cheng Hong 2,3,4,5, Jianmin Lu 2,3,4,5, Chunying Zhuang 2,3,4,5, Haimin Liu 2,3,4,5, Yue Zhong 2,3,4,5*, and Nuofu Zhang 2,3,4,5‡
doi : 10.1164/rccm.202105-1231le
Volume 204, Issue 10, PP. 1235–1236
Ina E. Djonlagic 1*, Meng Guo 2, Moroke Igue 1, Divya Kishore 1, Robert Stickgold 1, and Atul Malhotra 3
doi : 10.1164/rccm.202106-1414le
Volume 204, Issue 10, PP. 1236–1237
Natalie Villafranco , Nidhy Varghese , Marianna Sockrider , Erin Ely , and Elizabeth Neptune
doi : 10.1164/rccm.20410p16
Volume 204, Issue 10, PP. P17–P18
Do you want to add Medilib to your home screen?